EU Recommends Parkinsonís Drug for Approval

(January 5, 2015) - The first new drug in 10 years for Parkinson’s disease has been recommended for approval by the European Committee for Medicinal Products for Human Use. If the European commission approves the drug, then Xadago (safinamide), will be available to patients with mid to late stage Parkinson’s as an add-on to existing therapies. Read more…